Rituximab in Previously Treated Primary Immune Thrombocytopenia Patients: Evaluation of Short- and Long-Term Efficacy and Safety

Publisher: Karger

E-ISSN: 1421-9662|132|1|24-29

ISSN: 0001-5792

Source: Acta Haematologica, Vol.132, Iss.1, 2013-12, pp. : 24-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content